SPENCER LEFEBVRE: Open Payments
NPI 1689306649 · NORWAY, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $126 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| GENZYME CORPORATION | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Grifols USA, LLC | 2 | $36 |
| Verona Pharma, Inc. | 1 | $32 |
| Ambu Inc. | 1 | $21 |
Products named: FASENRA, DUPIXENT, NUCALA, Prolastin-C Liquid, Ohtuvayre.
Industry payments across ME — which companies pay providers there.
